Literature DB >> 7489723

Fos is an essential component of the mammalian UV response.

M Schreiber1, B Baumann, M Cotten, P Angel, E F Wagner.   

Abstract

Mouse 3T3 fibroblasts lacking c-fos were employed to demonstrate an essential function of the UV-inducible transcription factor AP-1 (Fos/Jun) in the response to the cytotoxic effects of short-wavelength ultraviolet (UVC) radiation. Clonogenic survival and proliferation of cells lacking c-fos were drastically reduced following UV irradiation. This UV hypersensitivity manifests itself primarily in increased cell death, partly by apoptosis, and prolonged recovery time from UV-induced cell cycle arrest. Co-culture with wild-type cells did not ameliorate the hypersensitivity of mutant cells. Transcriptional induction of the c-Fos target genes collagenase I, stromelysin-1 and stromelysin-2 by UV is almost absent in cells lacking c-fos which correlates with a reduced UV induction of AP-1 DNA-binding and transactivation activity. The repair of UV-induced DNA lesions was not affected, as shown by unscheduled DNA synthesis and host cell reactivation assays. These data demonstrate that c-Fos is involved in a novel protective function other than DNA repair against the harmful consequences of UVC.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7489723      PMCID: PMC394643          DOI: 10.1002/j.1460-2075.1995.tb00218.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  57 in total

1.  The ability of a ternary complex to form over the serum response element correlates with serum inducibility of the human c-fos promoter.

Authors:  P E Shaw; H Schröter; A Nordheim
Journal:  Cell       Date:  1989-02-24       Impact factor: 41.582

2.  Redox regulation of fos and jun DNA-binding activity in vitro.

Authors:  C Abate; L Patel; F J Rauscher; T Curran
Journal:  Science       Date:  1990-09-07       Impact factor: 47.728

3.  Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor.

Authors:  R Schüle; P Rangarajan; S Kliewer; L J Ransone; J Bolado; N Yang; I M Verma; R M Evans
Journal:  Cell       Date:  1990-09-21       Impact factor: 41.582

4.  Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction.

Authors:  H F Yang-Yen; J C Chambard; Y L Sun; T Smeal; T J Schmidt; J Drouin; M Karin
Journal:  Cell       Date:  1990-09-21       Impact factor: 41.582

5.  Expression of different Jun and Fos proteins during the G0-to-G1 transition in mouse fibroblasts: in vitro and in vivo associations.

Authors:  K Kovary; R Bravo
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

6.  Effects of v-src oncogene activation on radiation sensitivity in drug-sensitive and in multidrug-resistant rat fibroblasts.

Authors:  D S Shimm; P R Miller; T Lin; P P Moulinier; A B Hill
Journal:  Radiat Res       Date:  1992-02       Impact factor: 2.841

7.  Rapid and preferential activation of the c-jun gene during the mammalian UV response.

Authors:  Y Devary; R A Gottlieb; L F Lau; M Karin
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

8.  c-JUN, JUN B, and JUN D differ in their binding affinities to AP-1 and CRE consensus sequences: effect of FOS proteins.

Authors:  R P Ryseck; R Bravo
Journal:  Oncogene       Date:  1991-04       Impact factor: 9.867

9.  Fos and Jun repress transcriptional activation by myogenin and MyoD: the amino terminus of Jun can mediate repression.

Authors:  L Li; J C Chambard; M Karin; E N Olson
Journal:  Genes Dev       Date:  1992-04       Impact factor: 11.361

10.  Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice.

Authors:  P Soriano; C Montgomery; R Geske; A Bradley
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

View more
  51 in total

1.  Mutants of Arabidopsis thaliana hypersensitive to DNA-damaging treatments.

Authors:  J E Masson; P J King; J Paszkowski
Journal:  Genetics       Date:  1997-05       Impact factor: 4.562

2.  14-3-3 proteins block apoptosis and differentially regulate MAPK cascades.

Authors:  H Xing; S Zhang; C Weinheimer; A Kovacs; A J Muslin
Journal:  EMBO J       Date:  2000-02-01       Impact factor: 11.598

3.  Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis.

Authors:  I Herr; D Wilhelm; T Böhler; P Angel; K M Debatin
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

4.  Regulation of ES cell differentiation by functional and conformational modulation of p53.

Authors:  K Sabapathy; M Klemm; R Jaenisch; E F Wagner
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

Review 5.  The nucleolus—guardian of cellular homeostasis and genome integrity.

Authors:  Ingrid Grummt
Journal:  Chromosoma       Date:  2013-12       Impact factor: 4.316

6.  UV irradiation-induced apoptosis leads to activation of a 36-kDa myelin basic protein kinase in HL-60 cells.

Authors:  M L Lu; M Sato; B Cao; J P Richie
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

7.  Rac regulation of transformation, gene expression, and actin organization by multiple, PAK-independent pathways.

Authors:  J K Westwick; Q T Lambert; G J Clark; M Symons; L Van Aelst; R G Pestell; C J Der
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

8.  Signal transduction into the nucleus: fifth colloquium on cellular signal transduction. Heidelberg, Germany, January 1996.

Authors:  F Marks; P Angel
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

9.  Increased c-fos mRNA expression by human fibroblasts contracting stressed collagen matrices.

Authors:  H Rosenfeldt; D J Lee; F Grinnell
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

10.  The C-terminal domain of c-fos is required for activation of an AP-1 site specific for jun-fos heterodimers.

Authors:  K McBride; M Nemer
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.